Skip to main content
Clinical Trials/NCT05708833
NCT05708833TerminatedNot Applicable

Intra-Osseous Access in Difficult Vascular Access Cases

Assistance Publique - Hôpitaux de Paris2 sites in 1 country3 target enrollmentStarted: March 2, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
3
Locations
2
Primary Endpoint
To demonstrate that the early recourse to the intraosseous route, from the first failure, makes it possible to obtain more quickly the correction of the failure of critical patient managed in prehospital setting.

Study Overview

Brief Summary

Thousands of peripheral venous accesses are inserted every day all over the world. Some of them, such as those inserted in emergency and / or in critical patients, are absolutely vital. In the particular context of prehospital care, the rate of failure of the first attempt to insert a peripheral venous access has been evaluated at 25%. Success rates of successive attempts were about 75%. Nevertheless, the final success rate is close to 100%.

Failure or delay in obtaining venous access can be life-threatening. Thus, alternatives to peripheral venous access have been proposed including intraosseous route recently made easier by the development of an automated puncture device (EZ-IO®), but still rarely used, especially on conscious patient.

Currently, the place of intraosseous venous access in critical patients is not determined.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patient, in prehospital setting, without venous access and after failure of the first attempt to place a peripheral venous access by a senior operator (doctor or nurse) AND
  • Patient with hemodynamic failure defined as:
  • systolic blood pressure (SBP) < 90 mm Hg (2 measures) or
  • cardiac arrest or
  • Any situation requiring intubation

Exclusion Criteria

  • 1- Age < 18 years
  • 2- Venous access already available
  • 3- Known contra-indications to intraosseous access (i.e. bilateral lesions):
  • Bone fracture
  • Skin infection
  • Osteoporosis
  • Osteomyelitis
  • Local burns
  • Recent failed intraosseous attempt
  • Prior surgery
  • Compartment syndrome
  • Every other local specific situations
  • 4- Pregnancy woman
  • 5- Patient with no national health or universal plan affiliation coverage

Outcomes

Primary Outcomes

To demonstrate that the early recourse to the intraosseous route, from the first failure, makes it possible to obtain more quickly the correction of the failure of critical patient managed in prehospital setting.

Time Frame: • In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour

• In patients requiring endo-tracheal intubation: time required to achieve intubation.

Secondary Outcomes

  • To evaluate morbidity depending on the strategy used.(Hours 72)
  • To determine the length of stay in hospital(Days 28)
  • To evaluate mortality depending on the strategy used.(Days 28)
  • To evaluate the patient's feedback, depending on the strategy used.(Immediately after the insertion of the catheter (opening of the perfusion) and on arrival at the hospital, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour)
  • To evaluate the team's feedback, depending on the strategy used.(Immediately after the insertion of the catheter (opening of the perfusion) and on arrival at the hospital, In patients with hemodynamic failure: Reach a systolic blood pressure correction, an average of 1 hour)
  • To characterize the conditions for implementation of the procedure, depending on the strategy used.(In patients requiring endo-tracheal intubation: Achieve intubation, an average of 1 hour)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials

Intra-Osseous Access in Difficult Vascular... | Clinical Trial